SULLIVAN OWEN J
Known title: DirectorCIK: 0001314486
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Goldman Sachs cuts NCR Voyix price target to $8. Goldman Sachs maintained a Neutral rating on NCR Voyix but lowered its price target to $8. This action follows the company's recent Q2 2026 earnings call. The new target is below the current average analyst estimate of $12.96, reflecting a cautious outlook from the firm.
Transaction History
| ASB | ▲ Buy | Grant | 36 | $1K | 9/15/2026 | View on chart |
| ASB | ▲ Buy | Grant | 38 | $1K | 6/15/2026 | View on chart |
| ASB | ▲ Buy | Grant | 44 | $1K | 3/16/2026 | View on chart |
| ASB | ▲ Buy | Grant | 4,585 | $125K | 2/1/2026 | View on chart |
| ASB | ▲ Buy | Grant | 45 | $1K | 12/15/2025 | View on chart |
| ASB | ▲ Buy | Grant | 45 | $1K | 9/15/2025 | View on chart |
| ASB | ▲ Buy | Grant | 50 | $1K | 6/16/2025 | View on chart |
| ASB | ▲ Buy | Grant | 51 | $1K | 3/17/2025 | View on chart |
| ASB | ▲ Buy | Grant | 4,972 | $125K | 2/1/2025 | View on chart |
| ASB | ▲ Buy | Grant | 255 | $7K | 12/11/2024 | View on chart |
| VYX | ▲ Buy | Option Exercise | 75,473 | $0 | 2/10/2023 | View on chart |
| VYX | ▼ Sell | Tax Withholding | 28,485 | $754K | 2/10/2023 | View on chart |
| VYX | ▲ Buy | Option Exercise | 22,876 | $0 | 1/3/2023 | View on chart |
| VYX | ▼ Sell | Tax Withholding | 10,318 | $242K | 1/3/2023 | View on chart |
| VYX | ▲ Buy | Option Exercise | 265,167 | $0 | 12/16/2022 | View on chart |
| VYX | ▼ Sell | Tax Withholding | 119,591 | $2.8M | 12/16/2022 | View on chart |
| VYX | ▲ Buy | Option Exercise | 91,619 | $0 | 2/8/2022 | View on chart |
| VYX | ▼ Sell | Tax Withholding | 37,462 | $1.4M | 2/8/2022 | View on chart |
| VYX | ▼ Sell | Tax Withholding | 72,598 | $2.9M | 12/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Barclays Raises ASB Price Target to $35, Maintains Overweight
Barclays has raised its price target for Associated Banc-Corp to $35 while maintaining an Overweight rating. This move aligns with the broader analyst consensus, where the average target is $34.20. The stock is currently trading near its 52-week high, reflecting recent strength compared to some finance peers. Investors are also awaiting the company's third-quarter earnings report scheduled for late October.
Barclays Raises ASB Price Target to $35, Maintains Overweight. Barclays has raised its price target for Associated Banc-Corp to $35 while maintaining an Overweight rating. This move aligns with the broader analyst consensus, where the average target is $34.20. The stock is currently trading near its 52-week high, reflecting recent strength compared to some finance peers. Investors are also awaiting the company's third-quarter earnings report scheduled for late October.